Sg Americas Securities, LLC Krystal Biotech, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 2,527 shares of KRYS stock, worth $481,140. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,527

Previous 762 231.63%

Holding current value

$481,140

Previous $140,000 228.57%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$174.7 - $213.66 $308,345 - $377,109	1,765 Added 231.63%	2,527 $460,000
Q2 2024 Jul 12, 2024	SELL	$153.12 - $183.64 $956,234 - $1.15 Million	-6,245 Reduced 89.13%	762 $140,000
Q1 2024 May 06, 2024	SELL	$108.01 - $179.35 $1.28 Million - $2.13 Million	-11,858 Reduced 62.86%	7,007 $1.25 Million
Q4 2023 Jan 12, 2024	SELL	$96.0 - $128.29 $199,104 - $266,073	-2,074 Reduced 9.9%	18,865 $2.34 Million
Q3 2023 Oct 13, 2023	BUY	$108.51 - $130.22 $2.27 Million - $2.73 Million	20,939 New	20,939 $2.43 Million
Q1 2023 Apr 28, 2023	SELL	$72.39 - $84.27 $2.39 Million - $2.79 Million	-33,060 Reduced 85.26%	5,714 $457,000
Q4 2022 Feb 02, 2023	BUY	$63.14 - $79.9 $2.3 Million - $2.91 Million	36,434 Added 1557.01%	38,774 $3.07 Million
Q3 2022 Oct 31, 2022	SELL	$64.85 - $82.4 $1.31 Million - $1.66 Million	-20,130 Reduced 89.59%	2,340 $163,000
Q2 2022 Jul 29, 2022	SELL	$48.93 - $73.47 $813,754 - $1.22 Million	-16,631 Reduced 42.53%	22,470 $1.48 Million
Q1 2022 Apr 29, 2022	SELL	$51.99 - $72.11 $695,054 - $964,038	-13,369 Reduced 25.48%	39,101 $2.6 Million
Q4 2021 Feb 07, 2022	BUY	$39.81 - $88.24 $11,465 - $25,413	288 Added 0.55%	52,470 $3.67 Million
Q3 2021 Nov 01, 2021	BUY	$52.01 - $71.77 $839,493 - $1.16 Million	16,141 Added 44.79%	52,182 $2.72 Million
Q2 2021 Aug 12, 2021	SELL	$62.14 - $81.82 $106,197 - $139,830	-1,709 Reduced 4.53%	36,041 $2.45 Million
Q1 2021 May 13, 2021	SELL	$59.42 - $85.46 $311,241 - $447,639	-5,238 Reduced 12.18%	37,750 $2.91 Million
Q4 2020 Feb 04, 2021	SELL	$40.64 - $61.38 $564,530 - $852,629	-13,891 Reduced 24.42%	42,988 $2.58 Million
Q3 2020 Nov 09, 2020	BUY	$37.76 - $48.49 $1.37 Million - $1.76 Million	36,203 Added 175.1%	56,879 $2.45 Million
Q2 2020 Jul 20, 2020	BUY	$37.03 - $60.0 $765,632 - $1.24 Million	20,676 New	20,676 $856,000

Others Institutions Holding KRYS

# of Institutions

310

Shares Held

24.4M

Call Options Held

483K

Put Options Held

364K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.89B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Krystal Biotech, Inc. Transaction History